Development of circulating inhibitor directed against factor VIII in patients with haemophilia-A.
D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy; D006801:Humans; D065227:Transfusion Reaction
D005169:Factor VIII